EP Patent

EP2538929A4 — PROLONGED DELIVERY OF THERAPEUTIC AGENTS TO AN OCULAR COMPARTMENT

Assigned to Johns Hopkins University · Expires 2014-07-09 · 12y expired

What this patent protects

Patent listed against Lotemax.

Drugs covered by this patent

Lotemax (LOTEPREDNOL ETABONATE) · Bausch Health

Patent Metadata

Patent number: EP2538929A4
Jurisdiction: EP
Classification: —
Expires: 2014-07-09
Drug substance claim: No
Drug product claim: No
Assignee: Johns Hopkins University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.